Li Y - Search Results

1

In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma.

Liu Q, Tian Y, Li Y, Zhang W, Cai W, Liu Y, Ren Y, Liang Z, Zhou P, Zhang Y, Bao Y, Li Y. Liu Q, et al. Among authors: li y. J Immunother Cancer. 2020 Dec;8(2):e001748. doi: 10.1136/jitc-2020-001748. J Immunother Cancer. 2020. PMID: 33323464 Free PMC article.

2

High-affinity human PD-L1 variants attenuate the suppression of T cell activation.

Liang Z, Tian Y, Cai W, Weng Z, Li Y, Zhang H, Bao Y, Li Y. Liang Z, et al. Among authors: li y. Oncotarget. 2017 Oct 10;8(51):88360-88375. doi: 10.18632/oncotarget.21729. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179441 Free PMC article.

3

A humanized TCR retaining authentic specificity and affinity conferred potent anti-tumour cytotoxicity.

Chen L, Tian Y, Zhan K, Chen A, Weng Z, Huang J, Li Y, Sun Y, Zheng H, Li Y. Chen L, et al. Among authors: li y. Immunology. 2018 Sep;155(1):123-136. doi: 10.1111/imm.12935. Epub 2018 May 7. Immunology. 2018. PMID: 29645087 Free PMC article.

4

ImmTAC/Anti-PD-1 antibody combination to enhance killing of cancer cells by reversing regulatory T-cell-mediated immunosuppression.

Zhang H, Li Y, Liu X, Liang Z, Yan M, Liu Q, Chen A, Bao Y, Zhou C, Li S, Yee C, Li Y. Zhang H, et al. Among authors: li s, li y. Immunology. 2018 Oct;155(2):238-250. doi: 10.1111/imm.12954. Epub 2018 Jun 14. Immunology. 2018. PMID: 29791021 Free PMC article.

5

High-affinity PD-1 molecules deliver improved interaction with PD-L1 and PD-L2.

Li Y, Liang Z, Tian Y, Cai W, Weng Z, Chen L, Zhang H, Bao Y, Zheng H, Zeng S, Bei C, Li Y. Li Y, et al. Cancer Sci. 2018 Aug;109(8):2435-2445. doi: 10.1111/cas.13666. Epub 2018 Aug 7. Cancer Sci. 2018. PMID: 29890018 Free PMC article.

6

High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells.

Liang Z, Li Y, Tian Y, Zhang H, Cai W, Chen A, Chen L, Bao Y, Xiang B, Kan H, Li Y. Liang Z, et al. Among authors: li y. Cancer Lett. 2019 Apr 10;447:164-173. doi: 10.1016/j.canlet.2019.01.016. Epub 2019 Jan 21. Cancer Lett. 2019. PMID: 30677447

7

High-affinity T cell receptors redirect cytokine-activated T cells (CAT) to kill cancer cells.

Kang S, Li Y, Bao Y, Li Y. Kang S, et al. Among authors: li y. Front Med. 2019 Feb;13(1):69-82. doi: 10.1007/s11684-018-0677-1. Epub 2019 Feb 5. Front Med. 2019. PMID: 30725257

8

Corrigendum to 'High-affinity human programmed death-1 ligand-1 variant promotes redirected T cells to kill tumor cells' [Cancer Lett. 447 (2019) 164-173].

Liang Z, Li Y, Tian Y, Zhang H, Cai W, Chen A, Chen L, Bao Y, Xiang B, Kan H, Li Y. Liang Z, et al. Among authors: li y. Cancer Lett. 2019 Jun 28;452:268-269. doi: 10.1016/j.canlet.2019.03.026. Epub 2019 Mar 28. Cancer Lett. 2019. PMID: 30929810 No abstract available.

9

Identification of Wheat Leaf Rust Resistance Genes in Chinese Wheat Cultivars and the Improved Germplasms.

Wu H, Kang Z, Li X, Li Y, Li Y, Wang S, Liu D. Wu H, et al. Among authors: li y, li x. Plant Dis. 2020 Oct;104(10):2669-2680. doi: 10.1094/PDIS-12-19-2619-RE. Epub 2020 Jul 30. Plant Dis. 2020. PMID: 32729796 Free article.

10

Single-cell transcriptomic profiling of non-hematopoietic circulating cells in mid-gestational mouse embryos.

Li Y, Chen Y, Zheng X, Gao Y, Zheng Y, Li Z, He H, Tang F, Liu B, Lan Y. Li Y, et al. Among authors: li z. J Genet Genomics. 2021 Jun 20;48(6):508-511. doi: 10.1016/j.jgg.2021.05.002. Epub 2021 May 25. J Genet Genomics. 2021. PMID: 34167915 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240,502 results

Search Page

Filters